文献库 | GeneLibs

没有分类项

CCND1

RIT2

SRSF1

RGS4

RIT1

点此处获得已收录的全部基因

Early clinical trial experience with vaccine therapies in non-small-cell lung c…

作者：Ho(Cheryl),Ochsenbein(Adrian F),Gautschi(Oliver),Davie… 期刊：Clin Lung Cancer 出版时间：2008-07-01

...cancer vaccines. Immunotherapy has advanced from using nonspecific immunomodulatory agents to lung c...
Lifestyle prescriptions for cancer survivors and their communities.

作者：Lajous(M),Mozaffarian(D),Mozaffarian(R),Schrag(D),Adam… 期刊：J Intern Med 出版时间：2011-01-25

...cancer death. However, the majority of cancer survivors will not die from cancer but from cardiovasc...
Surgery for gallbladder cancer: The need to generate greater evidence.

作者：Shrikhande(Shailesh V),Barreto(Savio G) 期刊：World J Gastrointest Surg 出版时间：2011-07-14

...cancer remain largely dismal to this day. Overall, the low incidence of gallbladder cancer around th...
Appraisal of progenitor markers in the context of molecular classification of b…

作者：Haviv(Izhak) 期刊：Breast Cancer Res 出版时间：2014-03-25

...cancer cases through innate sensitivities bequeathed to the cancer from its normal progenitor state....
Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth …

作者：Zhang(Yuxing),Wang(Chao),Wang(Haiwei),Wang(Kankan),Du(… 期刊：Cancer Lett 出版时间：2011-05-12

...cancer effect, significantly enhances the cytotoxicity of cisplatin in ovarian cancer. The in vitro ...
Stress influences on anoikis.

作者：Sood(Anil K),Lutgendorf(Susan K) 期刊：Cancer Prev Res (Phila) 出版时间：2011-07-19

...cancer development and progression. Although the connections between stress and cancer causation are...
Persistent vascular normalization as an alternative goal of anti-angiogenic can…

作者：Sato(Yasufumi) 期刊：Cancer Sci 出版时间：2011-08-26

...cancers. Cancers contain newly formed immature vessels devoid of firm coverage by pericytes. Several...
β2-microglobulin induces epithelial to mesenchymal transition and confers cance…

作者：Josson(Sajni),Nomura(Takeo),Lin(Jen-Tai),Huang(Wen-Chi… 期刊：Cancer Res 出版时间：2011-07-11

...cancer metastases and novel therapeutic targets for cancer therapy.
[ RANKL antibody for treatment of cancer treatment-induced bone loss (CTIBL)].

作者：Takahashi(Shunji) 期刊：Clin Calcium 出版时间：2011-10-25

...cancer may cause gonadal dysfunction and bone loss (cancer treatment-induced bone loss ; CTIBL) . Es...
Metabolic approaches to overcoming chemoresistance in ovarian cancer.

作者：Suh(Dong Hoon),Kim(Mi-Kyung),No(Jae Hong),Chung(Hyun H… 期刊：Ann N Y Acad Sci 出版时间：2011-10-28

...cancer. Metabolic alterations have been suggested to have a crucial role in cancer development. The ...

上一页 970 971 972 973 974 975 976 977 978 下一页

分类

搜索排行

点此处获得已收录的全部基因

联系方式

微信公众号